Barely Significant
← all excerpts

Two cases of trastuzumab deruxtecan-induced interstitial lung disease in advanced breast cancer.

Respirol Case Rep · 2022 · PMC8907559 · PMID 35280717

1
hedged sentence
closest p
boldest claim

The sentences

highly significantno p-value reported
To the best of our knowledge, this is the first such report in clinical practice, making it highly significant. status released display-pdf yes is-olf no is-manuscript no is-preprint no is-journal-matter no is-scanned no is-retracted no Revised 2021 Dec 14; Received 2021 Nov 7; Accepted 2022 Feb 19; Collection date 2022 Apr.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.